Zoloft may cause birth defects when a woman takes it during pregnancy. If you or a loved one has given birth to a child with a birth defect and the mother took Zoloft during pregnancy, you may be entitled to financial compensation.
Zoloft is prescribed for many purposes. Sertraline is used to treat depression, obsessive-compulsive disorder (bothersome thoughts that won’t go away and the need to perform certain actions over and over), panic attacks (sudden, unexpected attacks of extreme fear and worry about these attacks), posttraumatic stress disorder and others. Regardless of the reason of prescription, women who take this drug may experience a greater than average risk of infant child birth defects, including but not limited to heart defects, cleft palate, cleft lip, skeletal deformations and more. If your child experienced such a horrific side effect, please call our team of Zoloft lawyers today for a free case evaluation on how we can help.
Risks Associated With Zoloft
Research Studies Highlight Risks Associated With Zoloft
Pfizer introduced Zoloft, a selective serotonin reuptake inhibitor (SSRI), in 1991 for people suffering from obsessive-compulsive disorders, post-traumatic stress, and major depressive disorders. The anti-depressant, one of the best sold drugs until 2007, has been in thick of controversy following reports linking it to birth defects in newly born babies and other side effects. The FDA has also issued warnings informing consumers of the potential risk of children born with birth defects from mother administered Zoloft during pregnancy.
Independent Studies on Zoloft Side Effects
US Research Studies
Children born to women administered with Zoloft and other antidepressants are likely to suffer from seizers and premature birth problems, according to a study published in the American Journal of Obstetrics and Gynecology in May 2012. The Tennessee Medicaid study involving 228,876 pregnant women warned that SSRIs taken in the third trimester led to five-fold increase in the risk of seizures in newly born babies.
According to a new research published in the Human Reproduction journal in October 2012, antidepressants, such as Zoloft, cause potential health risk in women facing pregnancy problems and their unborn babies. The report based on reviewing of over 100 comprehensive studies found that these SSRIs did not offer any improved pregnancy outcome, but impacted the women in the form of higher rate of miscarriage, pregnancy complications, and neonatal issues. Newly born babies also suffer from neurobehavioral abnormalities, persistent pulmonary hypertension, congenital defects in vertebra, heart, abdominal, lungs, and skull due to the side effects caused by Zoloft and similar SSRIs, according to the study.
The US National Academy of Science has warned that use of Zoloft-class antidepressant by pregnant women impacts language development of their children. According to its research details made public in October 2012, exposure to SSRI drugs during the pre-natal stage delay infant’s developmental milestones due to.
The British Medical Journal reported in September 2009 that babies born to mothers administered with Zoloft during pregnancy had enhanced risk of congenital heart problems. A report in published in Times Magazine in July 2011 expressed concern that autism in new born babies could be a side effect of Zoloft taken by pregnant mothers. The report was based on findings of Kaiser Permanente researchers who documented 298 children with autism spectrum disorder born to women who used SSRIs during the first trimester.
In April 2011, a research finding presented at the American College of Cardiology’s annual meeting linked Zoloft to heart attack in men. The drug, according to the study funded by the National Institutes of Health, increases the risk atherosclerosis in the carotid artery responsible for blood supply to neck and brain. This leads to deposition of fat inside artery walls, which can enhance the chance of heart attacks.
International Research Studies
A Swedish research report published in the British Medical Journal on January 16th, 2012, claimed to have found a link between persistent pulmonary hypertension in newly born children and SSRI antidepressants, including Zoloft. According to the report, when pregnant women are administered with Zoloft and other antidepressant drugs, the fetus is exposed to sertraline and this increase the risk of PPHN. Babies born with this rare disorder suffer from breathing problems, brain damage, multiple organ failure, and death.
A study published in March 2012 edition of the British Journal of Clinical Pharmacology reported that Zoloft and similar SSRI drugs contributed to hypertension in pregnant women. The research carried on by Canadian scholars interviewed more than 1,200 women named in the Quebec Pregnancy Registry. All these women took SSRI anti-depressants and were diagnosed with pregnancy-induced high blood pressure.
In April 2012, a multinational study published in the Frontiers in Evolutionary Psychology journal questioned efficacy of SSRIs. The study claimed that side effects of these antidepressants outweigh their benefits. It presented a list of antidepressant side effects, such as brain neuron death, cognitive disorder, dementia, gastrointestinal problems, stroke, fractures, infertility, birth defects, depression relapse, suicidal tendency, tongue dyskinesia, etc.
Two research studies made public by Danish scholars at Aarhus University in October 2009 and 2010 have highlighted developmental delays and withdrawal syndrome in babies born to mothers prescribed with Zoloft during pregnancy.
Another Canadian research finding reported in the Neurology medical journal in October 2012 claimed that Zoloft, Prozac, and Paxila, three popular antidepressants, could cause life-threatening brain hemorrhage. The report was based on 16 controlled observational studies at the Western University of Ontario.
The Problem
Our firm is offering free nationwide case evaluations to families whose children were diagnosed with medical conditions at birth or shortly therafter when the mother ingested Zoloft during pregnancy. Specific birth defects include cardiac malformations (ASD, VSD, Left Hypoplastic Heart Syndrome, coarctation of the aorta, Tricuspid or Pulmonary Atresia, Pulmonary Stenosis, transposition of the great vessels or any other heart defect), neural tube defect, craniosynostosis, cleft lip, cleft palate, skeletal deformations, and club foot.
About Zoloft
Our team of attorneys are currently reviewing potential Zoloft® lawsuits involving women who took these drugs during early pregnancy and whose children suffered adverse side effects, including heart defects and cleft lip/palate, among with others.
Manufactured by Pfizer, Inc., Zoloft® is generically known as sertraline hydrochloride and is a drug prescribed to treat major depression in adults, as well as obsessive-compulsive disorder, panic and social anxiety disorders and post-traumatic stress disorder in both adults and children. Zoloft is classified as a selective serotonin reuptake inhibitor (SSRI) drug, meaning that it selectively affects serotonin. Serotonin is one of many chemicals in the brain called neurotransmitters, which pass messages between nerve cells, and has been linked in various studiesto an increased risk of birth defects.
The Food and Drug Administration (FDA) initially placed SSRI antidepressants, including Zoloft, in its pregnancy Category C. This pregnancy category means that animal reproduction studies have shown an adverse effect on the fetus, but there have not yet been adequate and well-controlled studies in humans. Pregnancy categories measure the teratogenic effects a drug has on a fetus. Teratogenic means that a drug or other substance is capable of interfering with the development of a fetus, so there could be serious risks to the unborn baby of a woman taking Zoloft while pregnant.
Birth defects or conditions that may be associated with the use of Zoloft include:
- Abdominal wall defects (infant omphalocele)
- Anal atresia (complete or partial closure of the anus)
- Cleft lip and cleft palate
- Clubfoot (one or both feet turn downward and inward)
- Heart (cardiac) defects
- Skull defect (craniosynostosis)
Zoloft was approved by the FDA and introduced into the market in 1991. Prior to 2002, the drug was approved only for use in adults ages 18 and over. In 2002, the FDA approved Zoloft to treat severe obsessive compulsive disorder in children ages six and older.
The FDA issued a Public Health Advisory on Dec. 8, 2005, warning that use of certain antidepressants during the first trimester of pregnancy may be associated with an increased risk of birth defects. The advisory was based on U.S. and Swedish studies showing that exposure to certain antidepressants increased the risk of heart defects, including atrial and ventrical septal defects, conditions in which the wall between the right and left sides of the heart is not completely developed.
Citing a study by Christina Chambers of the University of California, San Diego, that was published in the New England Journal of Medicine, Health Canada issued a strong warning in March 2006 to pregnant women or women who were trying to become pregnant that antidepressant drugs like Zoloft could potentially pose serious risks to unborn or even nursing babies.
A 2007 study published in the New England Journal of Medicine found a “significant association” between Zoloft and septal defects. A septal defect is a congenital defect that affects the structures of the heart. Septal defects can lead to the improper circulation of blood, making the heart work overtime. An atrial septal defect (ASD) is a hole in the wall between the heart’s two upper chambers. A hole in the wall between the two lower chambers is called a ventricular septal defect (VSD). Septal defects can be life threatening. According to the study, mothers who take Zoloft during pregnancy may double the risk of having an baby born with septal defects.
In another study published in the March 2010 issue of Pediatrics, researchers found a potential association between exposure to antidepressants in late pregnancy and a delay in normal motor development skills at six and 19 months of age. The same researchers, in a 2009 study published by British Medical Journal, found that women who were pregnant and taking certain antidepressants during the first trimester had an increased risk of giving birth to babies having various heart defects.
A recent study conducted by scientists at the University of Montreal and published online on May 31, 2010, in the Canadian Medical Association Journal suggests that women who take antidepressants like Zoloft during the first trimester of pregnancy are significantly more likely to suffer a miscarriage than women who do not take antidepressants.
The Archive of General Psychiatry published a report in July of 2011 linking SSRI antidepressants such as Zoloft to a potentially increased risk of autism spectrum disorders (ASDs) in babies born to mothers who took these drugs during the first trimester of pregnancy. Performed by researchers at the Kaiser Permanente Medical Care Program in Northern California, the population-based, case-control study compared a group of 298 children having varying degrees of autism and their mothers to another group of 1,507 randomly selected children and their mothers. Nearly 70 children from each group were exposed to antidepressants in the same class as Zoloft, and the researchers found a possible connection between mothers who took these drugs within a year before delivery and an increased the risk of their babies being born with ASDs. The highest risk was found to be among those whose mothers took these drugs during the first trimester.
For a Free Case Evaluation:
TOLL FREE: 1-800-632-1404
EMAIL: click here
FILL OUT THIS FORM:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.